Screener
CONMED CNMD Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Payments on term loan | — | (54,821) |
| Proceeds from term loan | 450,000 | 25,234 |
| Payments on revolving line of credit | (402,000) | (337,432) |
| Proceeds from revolving line of credit | 595,000 | 341,432 |
| Repurchases of common stock | (43,221) | — |
| Payments to repurchase convertible notes | (637,176) | — |
| Payments related to contingent consideration | (28,853) | (14,094) |
| Payments related to debt issuance costs | (3,547) | (2,897) |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's debt issuance proceeds?
- CONMED (CNMD) reported debt issuance proceeds of $415M in Q2 2026.
- How has CONMED's debt issuance proceeds changed year-over-year?
- CONMED's debt issuance proceeds increased by 136.6% year-over-year, from $175.43M to $415M.
- What is the long-term trend for CONMED's debt issuance proceeds?
- Over 4 years (2021 to 2025), CONMED's debt issuance proceeds has grown at a 20.8% compound annual growth rate (CAGR), from $326.75M to $695.43M.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about CONMED's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude